Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum 180 Life Sciences Corp ATNF

Technology Information Technology Services

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. The Company is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). The Company has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR... see more

Add To Watchlist

Bullboard (NDAQ:ATNF)

View:

Post by Iseneschalon Jan 25, 2023 1:06pm

ATNF....... Rallying !

Me ...no position

69

Post by PressReleaseon Jan 25, 2023 8:45am

New Press Release - 180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren's Disease

PALO ALTO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced the publication of a review entitled ‘Treatments for early stage Dupuytren’s disease: an evidence-based approach’ in The Journal of Hand Surgery...read article.

Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company

posted Dec 22, 2024 9:00am by Voyageur Pharmaceuticals Ltd

Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more

Post by PressReleaseon Jan 17, 2023 8:00am

New Press Release - 180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United Kingdom

PALO ALTO, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company has engaged Kinexum, a strategic advisory firm, to support the Company in submitting a Marketing Authorisation Application (MAA) for...read article.

Post by PressReleaseon Jan 10, 2023 1:56pm

New Press Release - Newman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)

Newman Ferrara LLP announced today that it has an ongoing investigation into actions taken by officers and directors of KBL Merger Corp. IV (“KBL”), a special purpose acquisition company (“SPAC”) in connection to its merger with 180 Life Sciences Corp. (NASDAQ:ATNF) (the “Merger”) that was...read article.

Post by PressReleaseon Jan 05, 2023 8:30am

New Press Release - 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

PALO ALTO, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company received a letter on January 4, 2023 from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained full...read article.

Post by PressReleaseon Jan 04, 2023 8:30am

New Press Release - 180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren's Disease

PALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced the publication of a review entitled ‘Dupuytren’s disease: a localized and accessible human fibrotic disorder’ in the journal Trends in Molecular...read article.

Post by PressReleaseon Dec 29, 2022 8:30am

New Press Release - 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders

PALO ALTO, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Dear Fellow Shareholder,As we come to the end of 2022, I am pleased to provide an update for our shareholders. In keeping with good corporate practice and US Securities and Exchange Commission (SEC) regulations, we have refrained from answering...read article.

Comment by Iseneschalon Dec 28, 2022 10:08am

RE:Cha Ching !

Added to position this a.m......sold on the pop over $1.90 No position Thanks for the dough Cheers !

74

Discussion

Post by Iseneschalon Dec 27, 2022 4:03pm

ATNF..... LoL.....sure is funny what happens in the....

last half hour of trading

112

Post by Iseneschalon Dec 27, 2022 3:40pm

Cha Ching !

Cheers ! Swing position.... c u tomorrow.....rain or shine !

153

Discussion

Post by Iseneschalon Dec 27, 2022 3:39pm

ATNF .... Big add sub $1.81....

Gave it right back to Mr. M.....Cheers !

101

Post by Iseneschalon Dec 27, 2022 2:57pm

ATNF ..... a break of ~ $2.09 will be meaningful

Wait for it

89

Post by Iseneschalon Dec 27, 2022 2:52pm

ATNF ....don't give up on this

JMHO

91

Post by Iseneschalon Dec 27, 2022 2:49pm

ATNF..... Pop goes the weasel !

Cheers

102

Post by Iseneschalon Dec 27, 2022 1:48pm

ATNF ..... so all those peeps that paid $3.50

I'd say they all want their money back Hang in there ; )

110

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities

Featured News Links

Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments